1. Home
  2. SION vs STKL Comparison

SION vs STKL Comparison

Compare SION & STKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • STKL
  • Stock Information
  • Founded
  • SION 2019
  • STKL 1973
  • Country
  • SION United States
  • STKL United States
  • Employees
  • SION N/A
  • STKL N/A
  • Industry
  • SION
  • STKL Precious Metals
  • Sector
  • SION
  • STKL Basic Materials
  • Exchange
  • SION NYSE
  • STKL Nasdaq
  • Market Cap
  • SION 871.7M
  • STKL 771.1M
  • IPO Year
  • SION 2025
  • STKL N/A
  • Fundamental
  • Price
  • SION $16.92
  • STKL $5.70
  • Analyst Decision
  • SION Strong Buy
  • STKL Strong Buy
  • Analyst Count
  • SION 1
  • STKL 2
  • Target Price
  • SION $32.00
  • STKL $9.50
  • AVG Volume (30 Days)
  • SION 136.3K
  • STKL 888.0K
  • Earning Date
  • SION 08-25-2025
  • STKL 08-06-2025
  • Dividend Yield
  • SION N/A
  • STKL N/A
  • EPS Growth
  • SION N/A
  • STKL N/A
  • EPS
  • SION N/A
  • STKL N/A
  • Revenue
  • SION N/A
  • STKL $740,934,000.00
  • Revenue This Year
  • SION N/A
  • STKL $10.94
  • Revenue Next Year
  • SION N/A
  • STKL $8.49
  • P/E Ratio
  • SION N/A
  • STKL N/A
  • Revenue Growth
  • SION N/A
  • STKL 12.92
  • 52 Week Low
  • SION $7.26
  • STKL $3.65
  • 52 Week High
  • SION $25.19
  • STKL $8.11
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • STKL 38.19
  • Support Level
  • SION N/A
  • STKL $6.17
  • Resistance Level
  • SION N/A
  • STKL $6.68
  • Average True Range (ATR)
  • SION 0.00
  • STKL 0.26
  • MACD
  • SION 0.00
  • STKL -0.09
  • Stochastic Oscillator
  • SION 0.00
  • STKL 12.68

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.

Share on Social Networks: